Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial

Article ID	Journal	Published Year	Pages	File Type
6000706	Thrombosis Research	2015	8 Pages	PDF

Abstract

Rivaroxaban treatment resulted in improved treatment satisfaction compared with enoxaparin/VKA in PE patients, particularly in reducing patient-reported anticoagulation burden.

Keywords

ACTS NOAC VKA LMWH VTE Pulmonary embolism vitamin K antagonist standard deviation ITT Venous thromboembolism Venous thrombosis Deep vein thrombosis DVT standard error Treatment satisfaction Rivaroxaban intention-to-treat hazard ratio Low molecular weight heparin Least-squares

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial

Authors

Martin H. Prins, Luke Bamber, Stefan J. Cano, Maria Y. Wang, Petra Erkens, Rupert Bauersachs, Anthonie W.A. Lensing,